NIHON YAKKEN CO., LTD. – Trademark Portfolio
Entity Type: 99
NIHON YAKKEN CO., LTD. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 3 Nice Classification classes. Currently, 10 trademarks are registered. Notable registered marks include QDG, QDT, GOLDVEGE, THE GOLDEN, and NIHON YAKKEN.
20-15, SHINBASHI 2-CHOME,
MINATO-KU TOKYO-TO 105-0004
Showing of trademarks Trademarks
Trademark Classifications
NIHON YAKKEN CO., LTD.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does NIHON YAKKEN CO., LTD. have?
NIHON YAKKEN CO., LTD. has 10 U.S. trademarks filed with the USPTO. Of these, 10 registered.
What trademark classes does NIHON YAKKEN CO., LTD. file in?
NIHON YAKKEN CO., LTD. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are NIHON YAKKEN CO., LTD.'s most well-known trademarks?
NIHON YAKKEN CO., LTD.'s registered trademark portfolio includes well-known marks such as QDG, QDT, GOLDVEGE, THE GOLDEN, and NIHON YAKKEN. These are among 10 currently registered trademarks in the portfolio.
What is NIHON YAKKEN CO., LTD.'s trademark registration success rate?
NIHON YAKKEN CO., LTD. has a 100% trademark registration rate, with 10 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.